Target intelligence / Profile preview

Mitochondria-mediated caspase pathway (also known as mitochondrial pathway of apoptosis or intrinsic apoptosis pathway) (None)

Target
None
Molecular classification
Other (signaling pathway), Composed of enzymes (caspases: cysteine proteases), Regulatory proteins (Bcl-2 family), Apoptotic effector molecules (e.g., cytochrome c, Apaf-1)
01

Overview

The mitochondria-mediated caspase pathway (mitochondrial or intrinsic apoptosis pathway) is a highly conserved cellular process regulating programmed cell death in response to internal cues such as DNA damage, oxidative stress, or loss of survival signals. Central to this pathway is mitochondrial outer membrane permeabilization, governed by interactions between pro- and anti-apoptotic Bcl-2 family proteins. Once permeabilization occurs, cytochrome c and other apoptogenic factors are released into the cytosol, leading to apoptosome formation, activation of initiator caspase-9, and a cascade resulting in cell demolition via effector caspases. The integrity of this pathway is crucial in cancer, neurodegeneration, immune regulation, and tissue homeostasis, with numerous drugs under investigation aimed at modulating its molecular components for therapeutic benefit[1][2][3].

Other names
mitochondrial pathway of apoptosisintrinsic apoptosis pathwayintrinsic death pathwaycaspase-dependent mitochondrial apoptosis
02

Mechanism of action

Induction of mitochondrial outer membrane permeabilization; Release of cytochrome c and pro-apoptotic factors; Activation of initiator caspase-9 via apoptosome, and downstream effector caspases (e.g., caspase-3/7); Inhibition of anti-apoptotic Bcl-2 proteins promotes apoptosis

03

Biological functions

Apoptosis (programmed cell death)Cell deathRegulation of immune responseMitochondrial outer membrane permeabilization (MOMP)
04

Disease associations

Cancer (deficient apoptosis contributes to tumor survival)Neurodegenerative diseases (excess or dysregulated apoptosis)Cardiovascular diseases (e.g., ischemia/reperfusion injury)Other (autoimmune conditions, inflammation)
05

Safety considerations

Off-target induction of apoptosis in normal tissues may cause toxicityTumor cell resistance via overexpression of anti-apoptotic Bcl-2 family proteinsImmune suppression if excessive apoptosis is triggered
06

Interacting drugs

Venetoclax (Bcl-2 inhibitor)

4 more in the full profile.

07

Biomarkers

Cleaved caspase-3, caspase-9Cytosolic cytochrome cSmac/DIABLO in cytoplasmAnnexin V positivity (early apoptosis)

Beyond the preview

Go deeper on Mitochondria-mediated caspase pathway (also known as mitochondrial pathway of apoptosis or intrinsic apoptosis pathway) (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondria-mediated caspase pathway (also known as mitochondrial pathway of apoptosis or intrinsic apoptosis pathway) (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call